Lisa M. Pitchford
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
26
Citations
523
Est. group size
~12
Recurring co-author estimate
Active years
9
Publishing since 2017
Typically publishes in teams of ~8 · 11% small-team papers (≤3 authors) · across 12 venues
- Reactive Dicarbonyl Scavenging with 2-Hydroxybenzylamine Improves MASH
Nutrients · 2025
- 2-Hydroxybenzylamine for Treatment of Atrial Fibrillation: A First-in-Human Clinical Pilot Trial
Circulation Arrhythmia and Electrophysiology · 2025
- International society of sports nutrition position stand: β-hydroxy-β-methylbutyrate (HMB)
Journal of the International Society of Sports Nutrition · 2024
- Small-Scale Randomized Controlled Trial to Explore the Impact of β-Hydroxy-β-Methylbutyrate Plus Vitamin D3 on Skeletal Muscle Health in Middle Aged Women
Nutrients · 2022
- Impact of beta‐Hydroxy‐beta‐methylbutyrate plus Vitamin D <sub>3</sub> Supplementation on Skeletal Muscle Size, Function and Quality in Sedentary and Resistance Exercise Trained Women
The FASEB Journal · 2022
- 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device
Trials · 2021
- Health and ergogenic potential of oral adenosine-5′-triphosphate (ATP) supplementation
Journal of Functional Foods · 2021
- Probiotic <i>Bacillus coagulans</i> GBI‐30, 6086 Supplementation Improves β‐Hydroxy‐β‐methylbutyrate Bioavailability
The FASEB Journal · 2021
- Long-term Effects of Calcium β-Hydroxy-β-Methylbutyrate and Vitamin D3 Supplementation on Muscular Function in Older Adults With and Without Resistance Training: A Randomized, Double-blind, Controlled Study
The Journals of Gerontology Series A · 2020
- Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
BMC Pharmacology and Toxicology · 2020
- First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers
BMC Pharmacology and Toxicology · 2019
- Effects of Reactiv “Maximum HMB” on Body Mass and Performance in Elite Male Rugby Players
The Journal of Strength and Conditioning Research · 2019
- Acute and 28-day repeated dose toxicity evaluations of 2-hydroxybenzylamine acetate in mice and rats
Regulatory Toxicology and Pharmacology · 2018
- Subchronic (90-day) repeated dose toxicity study of 2-hydroxybenzylamine acetate in rats
Regulatory Toxicology and Pharmacology · 2018
- In vitro safety pharmacology evaluation of 2-hydroxybenzylamine acetate
Food and Chemical Toxicology · 2018
- Regulatory Toxicology and Pharmacology×4
- BMC Pharmacology and Toxicology×2
- Nutrients×2
- The FASEB Journal×2
- The Journal of Clinical Endocrinology & Metabolism×1
- Gregory C. Henderson
Biochemistry, Genetics and Molecular Biology · Purdue University West Lafayette
- Amanda K. Fox
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Catherine Sáenz
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Daniel J. Freidenreich
Biochemistry, Genetics and Molecular Biology · The Ohio State University
- Jeffrey F. Horowitz
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile